Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Preliminary Efficacy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00032292
What this trial is testing

Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Facet Biotech 34
Early research (Phase 1)Looking for participantsNCT05426681
What this trial is testing

Spinal Cord Injury Neuroprotection With Glyburide

Who this might be right for
Acute Spinal Cord Injury
Francis Farhadi 12
Testing effectiveness (Phase 2)Study completedNCT06139211
What this trial is testing

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai Junshi Bioscience Co., Ltd. 66
Early research (Phase 1)Study completedNCT01120457
What this trial is testing

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Who this might be right for
Acute Myelogenous LeukemiaDiffuse Large B-Cell LeukemiaChronic Lymphocytic Leukemia+1 more
Bristol-Myers Squibb 96
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07828639
What this trial is testing

VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo

Who this might be right for
Non-Segmental Vitiligo
Jiangsu vcare pharmaceutical technology co., LTD 10
Very early researchLooking for participantsNCT07378436
What this trial is testing

A Clinical Study of GK02 in Malignant Ascites

Who this might be right for
Malignant Ascites Caused by Advanced Solid Tumors
Beijing Geekgene Technology Co., LTD 9
Not applicableStudy completedNCT03968432
What this trial is testing

Parent Targeted Interventions in Vaccination Pain Management of Infants

Who this might be right for
Procedural Pain
University of Ottawa 151
Early research (Phase 1)Not Yet RecruitingNCT07232147
What this trial is testing

Clinical Research on Stem Cell Therapy for Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)Neurodegenerative DiseasesMovement Disorders
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. 20
Early research (Phase 1)Looking for participantsNCT07670858
What this trial is testing

Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC)

Who this might be right for
Nodular Basal Cell Carcinoma
Feldan Therapeutics 48
Testing effectiveness (Phase 2)UnknownNCT05842785
What this trial is testing

TSN222 in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
Tyligand Bioscience (Shanghai) Limited 162
Early research (Phase 1)Looking for participantsNCT05410717
What this trial is testing

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
Stage IV Ovarian CancerTestis Cancer, RefractoryEndometrial Cancer Recurrent+1 more
Second Affiliated Hospital of Guangzhou Medical University 200
Early research (Phase 1)Study completedNCT05190068
What this trial is testing

HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
B-Cell Non-Hodgkin's Lymphoma
Hutchmed 89
Testing effectiveness (Phase 2)WithdrawnNCT05181865
What this trial is testing

Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors

Who this might be right for
Pancreas CancerGastric CancerSolid Tumor
Flame Biosciences
Early research (Phase 1)Active Not RecruitingNCT04973163
What this trial is testing

Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

Who this might be right for
Solid Tumors, KRAS Mutation
Boehringer Ingelheim 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03019406
What this trial is testing

Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa

Who this might be right for
Glycogen Storage Disease Type II-Pompe's Disease
Genzyme, a Sanofi Company 22
Not applicableUnknownNCT04657848
What this trial is testing

Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy

Who this might be right for
Gastric CancerReflux Esophagitis
Zhejiang Cancer Hospital 100
Early research (Phase 1)Looking for participantsNCT05798897
What this trial is testing

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma, AdultNon-Hodgkin Lymphoma, RefractoryNon-Hodgkin Lymphoma, Relapsed+4 more
Marker Therapeutics, Inc. 79
Very early researchStudy completedNCT01688440
What this trial is testing

ETCare: Safety and Preliminary Efficacy Trial

Who this might be right for
Respiratory Distress Syndrome, Newborn
Intermountain Health Care, Inc. 10
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06763965
What this trial is testing

Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

Who this might be right for
Recurrent High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd 30
Early research (Phase 1)Study completedNCT00257738
What this trial is testing

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Maryland, Baltimore 17
Next Page